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PrognosisAbstract Introduction: The occurrence of colorectal cancer during pregnancy is rare and is
associated with diagnostic and therapeutic challenges. Herein, we report such a case of rectal cancer
in pregnancy and review the literature.
Case report: A 31-year-old multiparous, pregnant woman, in the 20th week of gestation, presented
with rectal bleeding progressing to spasmodic abdominal pain and right ﬂank vague pain. A ﬂexible
rectosigmoidoscopy showed a large ulcerative mass located in the rectosigmoid junction, 15 cm
away from anal verge. Imaging studies and biopsy proved it to be rectal adenocarcinoma with single
liver metastasis. The patient’s pregnancy was terminated and neoadjuvant therapy followed by
curative surgery was performed. She is currently receiving adjuvant systemic therapy to eradicate
potential micrometastatic disease.
Conclusion: This case suggests that colorectal cancer can mimic the signs and the symptoms of
pregnancy and tends to present at an advanced stage in pregnant women.
ª 2014 Production and hosting by Elsevier B.V. on behalf of National Cancer Institute, Cairo University.Introduction
In developing countries, colorectal cancer is the ﬁfth most
common cancer in men and third in women [1]. However,
the occurrence of colorectal cancer in women under 40 is
uncommon and it is very rare during pregnancy [2]. The inci-
dence of cancer in pregnancy ranges from 0.02% to 0.1%.
Colorectal cancer is one of the eight most frequent malignant
neoplasms in pregnancy [3]. This rare condition is associated
with diagnostic and therapeutic challenges [4]. The signs and
Figure 2 Trucut biopsy of the liver which shows involvement by
well differentiated adenocarcinoma, H&E, ·100.
176 M. Toosi et al.the symptoms of the pregnancy can mask colorectal cancer in a
pregnant woman and lead to late diagnosis in advanced stages
and poor treatment outcome [5]. In the present study, we re-
port such a case of advanced rectal cancer presented during
pregnancy.
Case report
A 31-year-old multiparous, pregnant woman (gravid 3, para
1), in the 20th week of gestation, presented with a 4-week his-
tory of rectal bleeding progressing to spasmodic abdominal
pain and right ﬂank vague pain. The patient’s past medical
and family history was negative for malignancy. An abdominal
and pelvis ultrasound showed an alive single 20th week fetus,
wall thickening of rectosigmoid junction and a large single
hypoechoic lesion in right posterior liver lobe. A ﬂexible
rectosigmoidoscopy showed a large ulcerative lesion in recto-
sigmoid junction 15 cm to 22 cm away from anal verge.
Transrectal biopsy of the rectal lesion revealed well differentiated
adenocarcinoma of the rectum (Fig. 1). An ultrasound-guided
core needle biopsy of the liver lesion conﬁrmed metastatic
rectal adenocarcinoma (Fig. 2). The patient was discussed in
a multidisciplinary medical council including specialities of
gynecologic oncology, perinatologist, surgical oncology,
medical oncology and radiation oncology. Therefore, termination
of pregnancy and neoadjuvant chemotherapy and chemoradi-
ation were suggested for the patient’s potentially resectable
stage IV rectal cancer. According to the medical council sug-
gestion, as well as the patient’s desire for therapeutic abortion,
a computed tomography (CT) scan of the chest, abdomen and
pelvis was performed for precise staging. In abdominal and
pelvic CT scan, there was a single fetus (Fig. 3), and a locally
advanced rectal tumor as signiﬁcant wall thickening of
rectosigmoid junction associated with enlarged perirectal and
mesenteric lymph nodes. In addition, there was a large single
mass in right posterior liver lobe (Fig. 4).
Therefore, the patient’s pregnancy was terminated and
2 weeks later she was referred for neoadjuvant therapies. The
patients received a cycle of neoadjuvant chemotherapy consist-
ing of capecitabine 1000 mg/m2 twice daily for 14 of everyFigure 1 Rectosigmoid adenocarcinoma showing well differen-
tiated glands containing atypical cells with high N/C ratio,
hyperchromatism and stratiﬁcation, H&E, ·400.
Figure 3 Contrast enhanced CT image of the abdomen and
pelvis showing a single intrauterine fetus.three weeks cycle, plus oxaliplatin 130 mg/m2 intravenously
on day 1 (CAPEOX regimen); followed by concurrent neoad-
juvant chemoradiation. Concurrent chemotherapy consists
of oxaliplatin 130 mg/m2 intravenously on day 1, plus oral
capecitabine 825 mg/m2 twice daily during the whole period
of radiotherapy with weekend breaks. Two weeks after
Figure 4 Contrast enhanced CT image of the abdomen and
pelvis showing signiﬁcant tumoral wall thickening of rectosigmoid
junction (white arrow) associated with liver mass (black arrow).
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Rectal cancer in pregnancy: A diagnostic and therapeutic challenge 177completion of chemoradiation, she received the 3rd cycle of
neoadjuvant chemotherapy. Before surgical intervention, a
new abdominal and pelvic CT scan showed marked regression
of the rectal tumor; however, liver metastasis showed some-
what progression. The patient subsequently underwent staged
curative surgical resection of the primary rectal tumor and
liver metastasis. Adjuvant chemotherapy combined with
targeted therapy using bevacizumab has been considered for
the patients to eradicate potential micrometastatic disease.
Discussion
There are many challenging issues regarding the diagnosis and
management of colorectal cancer in pregnancy [6]. Colorectal
cancer can be masked by the signs and the symptoms of the
pregnancy. Spasmodic abdominal pain secondary to the par-
tial large bowel obstruction may be considered as normal uter-
ine cramps. As well, anorectal bleeding and pain may be
misdiagnosed as a sequence of engorged hemorrhoid or anal
ﬁssure [2]. In our patient, occasional rectal bleeding and cram-
py abdominal pain was misdiagnosed as the signs and the
symptoms of normal pregnancy by the patient for a few weeks.
There are many limitations and contraindications for using
diagnostic tools during pregnancy [7,8]. Colonoscopy and
biopsy are golden standard tests for diagnosing colorectal can-
cer; however, this diagnostic test may complicate pregnancy
178 M. Toosi et al.and compromise the fetus. A gentle ﬂexible rectosigmoidos-
copy may be preferred in a suspicious pregnant women having
rectosigmoid cancer [4]. Ultrasound, a safe diagnostic modal-
ity in pregnancy, has limited accuracy in detecting colon and
rectal masses. Likewise, magnetic resonance imaging (MRI)
is relatively safe in pregnancy; however, the safety of contrast
agents used with this imaging has not been approved for the
fetus [8–10].
CT scan is the standard imaging study used for determining
the locoregional and distant disease in colorectal cancer. It
plays an important role for deﬁning the surgical and radiation
plans. However, X-ray imaging studies particularly the CT
scan is contraindicated during pregnancy due their teratogenic
and carcinogenic effects on the fetus. Therefore, there is a pau-
city of CT imaging ﬁndings in pregnancy in the literature
[8,10]. In our patient, CT scan was performed after deﬁnite
decision for terminating the pregnancy.
Treatment of colorectal cancer in pregnancy is another
challenging issue. As a rule, pregnant women should be offered
optimal management as non-pregnant patients. Therefore,
cancer treatment should be started as early as possible for
the mother. Likewise, pregnancy termination should be per-
formed as early as possible for saving the fetus. Accurate infor-
mation should be provided by the oncologist for the patient. A
treatment decision varies widely depending on the legal, ethi-
cal, personal, religious or emotional concepts [6,7,11]. Gener-
ally, in the ﬁrst 20 weeks of pregnancy, treatment delay can
lead to disease progression and compromise the mother’s life;
therefore, pregnancy would be terminated and early cancer
treatment should be started. In the second 20 weeks of preg-
nancy, surgery can be delayed for saving the fetus [3,7].
Most cases (64–86%) of colorectal cancer in pregnancy
tend to involve the rectum and mainly (60%) present at stage
III [12]. Therefore, a large portion of these patients need to re-
ceive neoadjuvant chemoradiation before rectal surgical resec-
tion [13,14]. However, pelvic radiation in pregnancy is
associated with lethal damage to the fetus. Radiation exposure,
particularly during organogenesis is contraindicated, because
it is associated with embryonic or fetal death, malformation,
and growth retardation [15]. In the literature, most rectal can-
cers in pregnancy occurred in the second or the third trimes-
ters. These patients tend to present in stage III or IV and to
have poor outcome [5,11,16–28] (Table 1). Most evidences
indicate that neoadjuvant chemotherapy in pregnant women
with metastatic rectal cancer spare the fetus; although it is
not curative for mothers [5,16,19–21]. In this report, our pa-
tient had a locally advanced disease in the pelvis associated
with resectable single liver metastasis; therefore, according to
the patient’s desire termination of pregnancy followed by com-
bined neoadjuvant chemotherapy and chemoradiation before
surgical intervention was offered to the patient. Subsequent
curative surgery and adjuvant systemic therapy was offered
to her.Conclusion
Herein, we report a case of advanced rectal cancer presenting
during pregnancy. This case suggests that colorectal cancer can
mimic the signs and the symptoms of pregnancy and tends to
present at an advanced stage in pregnant women.Conﬂict of interest
The authors have no commercial or other associations that
might pose a conﬂict of interest in connection with the
manuscript.
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